Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$179.8B
155M shares
52-week range
$917.39 – $1,219.94
88% from low
Sector
SECURITY BROKERS, DEALERS & FLOTATION COMPANIES
Exchange
NYSE
CS
BlackRock is the largest asset manager in the world, with $14.041 trillion in assets under management at the end of December 2025. Its product mix is diverse, with 55% of managed assets in equity strategies, 23% in fixed income, 9% in multi-asset classes, 6% in money market funds, and 5% in alternatives. Passive strategies account for more than two-thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which, by our calculations, account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one-third of managed assets coming from investors domiciled outside the US and Canada.
www.blackrock.comNo one on the platform currently holds BLK.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2025-12-31 | 4,581 | $4.9M |
| Renaissance Technologiesas of 2025-12-31 | 3,846 | $4.1M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-08 | $5.7300 | 2026-09-22 |
| 2026-06-05 | $5.7300 | 2026-06-23 |
| 2026-03-06 | $5.7300 | 2026-03-24 |
| 2025-12-05 | $5.2100 | 2025-12-23 |
| 2025-09-05 | $5.2100 | 2025-09-23 |
| 2025-06-05 | $5.2100 | 2025-06-23 |
| 2025-03-07 | $5.2100 | 2025-03-24 |
| 2024-12-05 | $5.1000 | 2024-12-23 |
| 2024-09-09 | $5.1000 | 2024-09-23 |
| 2024-06-07 | $5.1000 | 2024-06-24 |
No one on the platform has traded BLK yet.
| 2024-03-06 | $5.1000 | 2024-03-22 |
| 2023-12-06 | $5.0000 | 2023-12-22 |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $29.0B | +20.6% | $56.41 | $55.07–$57.99 | 21.0× | 9 |
| 2027 | $32.4B | +11.8% | $64.50 | $61.95–$66.58 | 18.3× | 9 |
| 2028 | $36.9B | +13.9% | $74.22 | $68.37–$80.08 | 15.9× | 2 |
| 2029 | $39.7B | +7.6% | $79.82 | $74.61–$82.90 | 14.8× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-15 | $12.69 | $13.91 | +9.6% |
| 2026-04-14 | $11.65 | $12.53 | +7.6% |
| 2026-01-15 | $12.24 | $13.16 | +7.5% |
| 2025-10-14 | $11.36 | $11.55 | +1.7% |
| 2025-07-15 | $10.78 | $12.05 | +11.8% |
| 2025-04-11 | $10.08 | $11.30 | +12.1% |
| 2025-01-15 | $11.27 | $11.93 | +5.9% |
| 2024-10-11 | $10.33 |
| $11.46 |
| +10.9% |
| $89.2B |
| — |
| BENFranklin Resources, Inc. | $33.86 | +0.80% | $17.6B | — |
| BKThe Bank of New York Mellon Corporation | $141.91 | -0.48% | $97.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$JNJ $SF $MS $BLK How’s your Friday going?
View on StockTwits ↗The Bank Of Nvidia: When Silicon Learns To Lend $NVDA $ORCL Also Mentions: $BLK $KKR https://talkmarkets.com/article/the-bank-of-nvidia-when-silicon-learns-to-lend-1786697579
View on StockTwits ↗$UBS $BTC.X $BLK UBS Buys More Bitcoin via Blackrock ETF https://coinmarketcap.com/community/articles/6a7e155e26303c2a30d06a3e
View on StockTwits ↗$BTC.X old money coming for that new money $BLK $JPM $MSTR $SPY
View on StockTwits ↗$SPY Omg I understand now. Your own Bitcoin strategy has turned upside down. For the first time in 7 years I finally see it moving up. $BITO Your face is finally revealed. I can’t believe it’s been you this whole time ProShares.. here I am blaming $BLK $JPM and $HOOD but it’s been you begging the scenes this whole time.
View on StockTwits ↗$SKHY Hold, thank $JPM $GS $BLK and Citadel, be grateful good stuff
View on StockTwits ↗🚀 $LXRX — The setup is becoming VERY hard to ignore. Part 2 🤑 This isn't just a “one drug” biotech anymore. It's commercial revenue + regulatory catalysts + global distribution + multiple Phase 3 shots + a Novo-backed obesity asset + rapidly growing institutional interest. And the beauty of the setup? LXRX doesn't need everything to hit. If ZYNQUISTA wins, HCM wins, Novo's program works, or another partnership lands, the valuation could look very different. The market sees a small biotech. I see a cardiometabolic platform with multiple ways to win. 🚀 The story is just getting started. Putting the pieces together, I think Lexicon is increasingly becoming an asymmetric cardiometabolic story. $LXRX $BLK $STT $VOO $NVO ...
View on StockTwits ↗🚀 $LXRX — The setup is becoming VERY hard to ignore. Part 1 🤑 The pieces are lining up: 🔥 Institutional accumulation: ~17M+ BlackRock + ~4.5–5M State Street shares, alongside major increases from Point72, Renaissance, Marshall Wace, Jane Street, Susquehanna & Geode. 💊 ZYNQUISTA: potential U.S. approval + major commercial opportunity. 🌎 Viatris: global commercialization infrastructure for sotagliflozin outside U.S./Europe. ❤️ SONATA-HCM: Phase 3, with topline data targeted for Q1 2027. 🤝 Novo Nordisk: worldwide LX9851 deal with up to $1B in potential milestones + royalties — massive validation and obesity optionality. 🧬 Pilavapadin: another potential partnering/Phase 3 catalyst. $LXRX $BLK $STT $VOO $NVO ...
View on StockTwits ↗📢 Citi Investor Services has won a full middle office mandate from Aegon Asset Management, covering US$380B in AUM. Full article: https://liquidityfinder.com/news/citi-investor-services-wins-full-middle-office-mandate-from-aegon-asset-management The deal extends full Investment Book of Record (IBOR) services, trade management/settlement and performance measurement via Aladdin Accounting. "This mandate significantly expands our relationship with Aegon AM... we warmly welcome our new colleagues to Citi as we build scale on Aladdin" — Mike Hughes, Head of Fund Services, Citi Investor Services Aegon AM's Budapest operations team has joined Citi as part of the deal. $C $BLK
View on StockTwits ↗$NVDA $BLK $APO $GS $BX Michael Burry slams Nvidia’s $500B Wall Street financing deal as a 2008-style "Wall Street Stunt." Source: Seeking Alpha ("Burry slams Nvidia's $500B AI financing as a 2008-style 'Wall Street stunt'") Here is the exact 6-step circular pipeline Burry exposed: 1. Pensioner Money: Retirees pay annuity premiums to Apollo's insurance arm, Athene. 2. Offshore Loophole: Apollo routes these funds through Bermuda offshore reinsurers to bypass US capital rules & maximize leverage. 3. Debt Injection: Apollo issues $3.5B in asset-backed debt to a Special Purpose Vehicle (SPV / Valor). 4. Nvidia Equity Kick: NVDA injects $1.9B of its OWN cash into the same SPV as equity. 5. Circular Revenue: The SPV uses the combined $5.4B to buy NVDA's GB200 GPUs (NVDA books this as "organic revenue"). 6. Risk Offloading: The SPV leases GPUs to AI startups (xAI). If GPU values crash or power grid delays hit, retirement funds swallow 75% of the loss while NVDA caps its exposure at 25%.
View on StockTwits ↗$BLK $APO The structural conflict inside nvda's $500B Wall Street deal exposed: 1. The Conflict of Interest: Nvidia controls its own chip obsolescence rate. By releasing Blackwell & Rubin, NVDA inherently destroys the value of previous-gen GPUs acting as collateral. 2. The 25% Cap Red Flag: NVDA capping its residual value support at 25% proves they know GPUs depreciate violently (H100 secondary prices already crashed 73% from $30K to $8K). They offloaded the remaining 75% risk onto pension funds & insurers. 3. Rating Agency Blindspot: Fitch hasn't even finalized the rating standards for GPU depreciation, yet $500B in debt is being securitized. 4. Lucent 2.0: Just like Lucent’s vendor financing collapse in 2000, off-balance-sheet SPVs are hiding the true negative equity of over-leveraged compute. $SOXL $SOXS
View on StockTwits ↗$LXRX $BLK $STT $VOO $NVO 🚨 📈 The More Interesting Active-Money Buyers 🚀📊😎 Beyond the large asset managers, Q1 2026 13F filings show notable position increases from several sophisticated, actively managed investment firms. These are particularly noteworthy as they reflect more discretionary capital allocation. Point72 Asset Management — Increased its position to ~7.81M shares (+2,651%), signaling strong new institutional conviction. Renaissance Technologies — Added ~1.337M shares, bringing its position to ~1.60M; the largest institutional purchase in Q1. FMR/Fidelity — Increased its position ~19% to ~45.1M shares. Millennium Management — Increased its position ~26% to ~4.82M shares. Vanguard Capital Management — Initiated or newly reported a ~9.5M-share position. Sessa Capital — Nearly quintupled its position, among the largest institutional increases. ... TUTES ARE LOADING $LXRX 🤑
View on StockTwits ↗$LXRX $BLK $STT $VOO $NVO 🚨 📈 BlackRock & State Street: A Powerful Institutional Accumulation Signal... Part 2 🚀📊😎 While these positions may include passive or index-related exposure, the direction and scale of the changes are still significant. Large institutional ownership increases can provide greater visibility, liquidity, and credibility within the investment community—and potentially create an increasingly supportive shareholder base as LXRX continues to execute on its pipeline and commercial strategy. For investors, the key takeaway is simple: LXRX is attracting materially greater institutional ownership across some of the largest asset managers in the world. Combined with the significant increases from active managers such as Point72, Renaissance, Sessa, Millennium, and Fidelity, the broader institutional picture is increasingly constructive. ...🤣🐳💰🚀
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.